Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed)
ID: 359646Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/359646
Timeline
    Description

    The National Institutes of Health (NIH) has announced a funding opportunity for the establishment of Animal and Biological Material Resource Centers under the Notice of Funding Opportunity (NOFO) RFA-OD-25-011. This initiative aims to support the creation, preservation, and distribution of high-quality laboratory animals and biological materials, while integrating new approach methodologies (NAMs) that complement traditional animal-based research. The program is designed to enhance research infrastructure and resource availability across various biomedical research areas, with a total funding amount of $1.3 million anticipated to support at least two awards annually from FY 2023-2025. Interested applicants must ensure their proposals demonstrate national need, include multi-component applications, and adhere to eligibility criteria, as foreign entities are not permitted to apply. For further inquiries, applicants can contact the Office of Research Infrastructure Programs at ORIPDCM@mail.nih.gov, with applications due by January 9, 2029.

    Point(s) of Contact
    ORIPDCM@mail.nih.gov
    Files
    Title
    Posted
    RFA-OD-25-011-Full-Announcement.html
    The Department of Health and Human Services (NIH) has reissued a Notice of Funding Opportunity (RFA-OD-25-011) for Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed). This NOFO, reissuing RFA-OD-23-001, encourages grant applications for centers that create, collect, develop, characterize, preserve, and distribute special colonies of high-quality laboratory animals and animal-related models, as well as biological materials, informatics tools, data, and analytical expertise. The goal is to support research infrastructure and resource programs under the Office of Research Infrastructure Programs (ORIP) and to integrate new approach methodologies (NAMs) that complement traditional animal-based research. Projects focusing on specific diseases or limited national impact, or those primarily involving human subjects, will not be supported. Applications must demonstrate a national need, serve various research areas, ensure resource quality, include an Applied Research Component (up to 15% of direct costs), and have a Curation and Informatics component. Funding of $1.3 million is anticipated to support at least two awards annually from FY 2023-2025, with a maximum project period of five years. Eligibility extends to various organizations, but foreign entities are excluded. Applications are multi-component, requiring an Overall, Resource, Curation and Informatics, and Applied Research component. Review criteria emphasize overall impact, significance, investigator qualifications, innovation, approach, and environment, with specific merit descriptors for each component.
    Similar Opportunities
    Animal and Biological Material Resource Centers (P40) (Clinical Trials Not-Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Animal and Biological Material Resource Centers" (P40) aimed at supporting specialized colonies of laboratory animals and related resources to enhance scientific rigor and reproducibility in biomedical research. This funding initiative encourages applicants to propose centers that not only continue existing resources but also develop new ones based on the needs of the biomedical research community, providing unique animal models, informatics tools, and biological materials applicable across multiple NIH Institutes. The total funding commitment is anticipated to be $1.3 million over three years, with at least two grants awarded annually, and interested applicants must adhere to strict application guidelines, with submissions accepted until January 28, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to announce a funding opportunity for the Animal and Biological Material Resource Centers under the P40 grant mechanism, aimed at supporting projects that develop and maintain animal models and related biological resources. This initiative seeks to enhance the scientific rigor and reproducibility of biomedical research by providing accessible resources, including special colonies of laboratory animals, informatics tools, and new approach methodologies (NAMs) that complement traditional animal-based research. With an estimated total program funding of $1,300,000 and the expectation of awarding two grants, interested small businesses should prepare for the application process, which will open in December 2025, with submissions due by February 2026. For further inquiries, potential applicants can contact Oleg Mirochnitchenko, PhD, at Oleg.mirochnitchenko@nih.gov or by phone at 301-435-0748.
    Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for the development of animal models and related biological materials for research, designated as an R21 Exploratory/Developmental Research Grant. This funding initiative aims to support innovative projects that enhance, characterize, and preserve animal models relevant to human health and diseases, with a focus on studies that encompass multiple body systems or disease categories rather than single-disease research. The total funding available is $200,000, with a project period limited to two years, and applications are due by January 7, 2028. Interested applicants can find more information and guidance by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-25-273.html.
    Informatics, Coordination and Service Center for the Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to publish a Notice of Funding Opportunity (NOFO) for the Informatics, Coordination and Service Center (ICSC) within the Mutant Mouse Resource and Research Centers (MMRRC) consortium, aimed at enhancing biomedical research through improved informatics services. The initiative seeks to support projects that develop and assist resources related to animal and biological materials, focusing on the integration of new approach methodologies (NAMs) alongside traditional animal-based research. This funding opportunity, utilizing the U42 activity code, is expected to provide a total of $878,000, with one award anticipated, and applications will be accepted starting in Summer 2025, following the NOFO publication in Spring 2025. For further inquiries, interested applicants can contact Dr. Oleg Mirochnitchenko at oleg.mirochnitchenko@nih.gov or by phone at 301-425-0479.
    Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for Resource-Related Research Projects aimed at developing models and methodologies for studying human health and diseases, specifically through the R24 grant mechanism, which does not allow clinical trials. This initiative, led by the Office of Research Infrastructure Programs (ORIP), seeks applications that focus on creating broadly applicable research models or new approach methodologies (NAMs) that can impact multiple organ systems and align with the interests of two or more NIH Institutes or Centers. The NIH plans to allocate $5 million annually from FY 2026 to FY 2029, with at least six awards expected each year, and projects can last up to four years. Interested applicants, excluding foreign organizations, must complete federal registrations prior to submission and can reach out to ORIPDCM@mail.nih.gov for further information.
    Notice of Intent to Publish a Funding Opportunity Announcement for Complement-ARIE New Approach Methodologies (NAMs) Technology Development Centers (UM1 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a funding opportunity announcement for the Complement-ARIE New Approach Methodologies (NAMs) Technology Development Centers, with a focus on advancing animal research in experimentation. This initiative aims to support the development of innovative methodologies that enhance the use of animal models in research, thereby improving the quality and relevance of scientific findings. The total estimated program funding is $18 million, with an award ceiling of $2 million per award, and the NIH anticipates making approximately four awards. Interested applicants should note that the estimated synopsis post date is October 18, 2024, with a closing date for applications expected by February 28, 2025, and awards anticipated to be made by December 1, 2025.
    Informatics, Coordination and Service Center for the Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity for the Informatics, Coordination and Service Center (ICSC) within the Mutant Mouse Resource and Research Centers (MMRRC) consortium. This funding aims to provide ongoing support for the ICSC, which is responsible for delivering informatics and coordination services to the MMRRC and biomedical researchers, including the development and maintenance of data management systems and facilitating interactions among researchers. The initiative emphasizes the integration of New Approach Methodologies (NAMs) to enhance traditional animal research, with an estimated total program funding of $878,000 and a projected award of one grant. Applications are due by May 1, 2026, and interested parties can contact Oleg Mirochnitchenko, Ph.D., at ORIPDCM@mail.nih.gov for further information.
    Nonhuman Primate Reagent Resource (U24 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a forthcoming funding opportunity titled "Nonhuman Primate Reagent Resource (U24 Clinical Trial Not Allowed)" aimed at supporting the development, production, and distribution of nonhuman primate-specific immunologic reagents. This initiative, led by the National Institute of Allergy and Infectious Diseases (NIAID), seeks to enhance preclinical research in nonhuman primate models to accelerate advancements in cures, vaccines, and treatments for immune-mediated diseases and emerging infectious diseases. The estimated total program funding is $1,300,000, with one award expected, and applications are anticipated to be solicited starting in late August 2025, with a closing date in late October 2025. Interested applicants can reach out to Dr. Shilpa Kulkarni at shilpa.kulkarni@nih.gov or call 240-747-7365 for further information.
    Limited Competition: National Primate Research Centers (P51) (Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for the Limited Competition: National Primate Research Centers (P51), aimed at supporting basic and translational research utilizing nonhuman primates (NHPs). This grant is specifically designed for existing National Primate Research Centers (NPRCs) to provide essential resources, expertise, and animal models crucial for advancing understanding of human biology in both normal and diseased states. The NPRCs play a vital role in biomedical research by ensuring rigorous study designs, facilitating pilot research projects, and promoting ethical treatment of research animals. Interested applicants must submit their proposals by January 25, 2024, with a maximum project period of five years, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found in the full announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-23-126.html.
    Notice of Intent to Publish a Funding Opportunity Announcement for Complement-ARIE New Approach Methodologies (NAMs) Data Hub and Coordinating Center (U24 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is planning to publish a Notice of Funding Opportunity Announcement (NOFO) for the Complement-ARIE New Approach Methodologies (NAMs) Data Hub and Coordinating Center, which will be available under the U24 activity code. This initiative aims to support the Complement Animal Research In Experimentation (Complement-ARIE) program, encouraging the research community to form collaborations and develop responsive projects. The funding opportunity is significant for advancing health-related research methodologies, with an estimated total program funding of $5 million and a single award anticipated. Interested applicants should note that the synopsis is expected to be posted on November 29, 2024, with a closing date of March 10, 2025, and an estimated award date of December 1, 2025.